Valuation: ViGenCell Inc.

Market Cap 20TCr 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 148.93Cr 58Cr 729.33Cr 56Cr 55Cr 2.34TCr P/E 2023
-6.24x
P/E 2024 -3.42x
Enterprise Value 16TCr 12Cr 11Cr 10Cr 9.12Cr 17Cr 1.16TCr 17Cr 121.04Cr 47Cr 592.71Cr 45Cr 44Cr 1.9TCr EV / Sales 2023
-
EV / Sales 2024 3,84,29,949x
Free-Float
73.87%
Yield 2023 *
-
Yield 2024 -
1 day-0.68%
1 week+1.57%
Current month+0.87%
1 month-7.19%
3 months+2.29%
6 months+14.82%
Current year-40.41%
1 week 5,450
Extreme 5450
6,660
1 month 5,450
Extreme 5450
7,000
Current year 4,320
Extreme 4320
14,400
1 year 3,070
Extreme 3070
17,360
3 years 2,305
Extreme 2305
17,360
5 years 2,305
Extreme 2305
21,975
10 years 2,305
Extreme 2305
39,000
Manager TitleAgeSince
Chief Executive Officer 68 -
Corporate Officer/Principal 48 27/03/2025
Director TitleAgeSince
Director/Board Member 68 27/03/2025
Director/Board Member 48 27/03/2025
Director/Board Member 55 27/03/2025
Date Insider Type Main position Quantity % Market Cap. Importance
30/04/24 Exercice 35,000 0.1826%
30/04/24 Exercice

Director

63,000 0.3287%
30/04/24 Don 40,440 0.2110%
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%+1.57%+62.75%+6.61% 8.84Cr
+4.16%+3.04%+49.37%+94.17% 7.42TCr
-3.11%-3.53%+20.19%+81.44% 5.74TCr
+0.89%-0.63%+2.17%+36.19% 4.76TCr
+0.36%+0.81%+342.39%+742.40% 4.43TCr
-0.96%-4.50%+24.96%+35.38% 4.25TCr
-0.20%-0.77%+4.13%+105.50% 4.07TCr
-0.54%+2.93%+9.31%+50.41% 3.1TCr
-2.68%+2.92%+29.33%+22.72% 2.85TCr
+0.05%-1.64%-8.14%-11.37% 2.43TCr
Average -0.27%-0.46%+53.65%+116.35% 3.91TCr
Weighted average by Cap. +0.12%-0.84%+56.96%+138.23%

Financials

2023 2024
Net sales - 278.95 0.21 0.18 0.17 0.16 0.3 19.91 0.3 2.08 0.81 10.18 0.78 0.76 32.67
Net income -1.79TCr -1.33Cr -1.18Cr -1.1Cr -1Cr -1.89Cr -127.6Cr -1.91Cr -13Cr -5.16Cr -65Cr -4.98Cr -4.88Cr -209.34Cr -1.41TCr -1.04Cr -92.73L -86.55L -78.88L -1.49Cr -100.33Cr -1.5Cr -10Cr -4.06Cr -51Cr -3.92Cr -3.83Cr -164.61Cr
Net Debt -4.6TCr -3.41Cr -3.03Cr -2.83Cr -2.58Cr -4.87Cr -328.08Cr -4.91Cr -34Cr -13Cr -167.72Cr -13Cr -13Cr -538.27Cr -3.74TCr -2.78Cr -2.47Cr -2.31Cr -2.1Cr -3.96Cr -267.25Cr -4Cr -28Cr -11Cr -136.62Cr -10Cr -10Cr -438.46Cr
Logo ViGenCell Inc.
ViGenCell Inc is a Korea-based company principally engaged in the development of cell therapy business. The Company is engaged in the development and manufacture of immuno-cancer cell therapy products and immunosuppressive cell therapy products. In addition, the Company is engaged in the provision of vitier platform as an antigen-specific killing t cell treatment, viranger platform as a gammadelta t cell gene therapy and vimedier platform-based technology as a myeloid suppressor cell therapy derived from umbilical cord blood. It is engaged in the research and development of new drugs such as acute myeloid leukemia (AML) and glioblastoma.
Employees
-
Date Price Change Volume
02/26/02 ₩5,810.00 -0.68% 48,268
01/26/01 ₩5,850.00 +1.56% 1,15,179
30/26/30 ₩5,760.00 +3.97% 82,058
29/26/29 ₩5,540.00 -3.99% 98,823
  1. Stock Market
  2. Stocks
  3. A308080 Stock